Abstract
A 31-year-old female presented with a 3-week history of fever and headache. CSF Ziehl-Neelsen smear microscopy revealed acid-fast bacilli, and CSF GeneXpert MTB/RIF was positive for Mycobacterium tuberculosis with no mutations of rifampicin resistance. Tuberculous meningitis (TBM) was diagnosed. Baseline contrast-enhanced brain magnetic resonance imaging (MRI) was unremarkable. Eight weeks later the patient developed markedly reduced visual acuity and clinical signs consistent with left 3rd and 6th cranial nerve palsies. Repeat contrast-enhanced brain MRI revealed extensive tuberculous exudate filling the basal cisterns of the brain consistent with a severe paradoxical reaction of TBM. High dose intravenous dexamethasone was administered, with visual acuity returning to near-normal over 3–4 weeks. In TBM paradoxical inflammatory reactions are common yet difficult to predict. When severe, they may result in substantial neurological morbidity and death. Prompt host directed therapies such as corticosteroids may reduce chances of permanent neurological damage.
Keywords: Tuberculous meningitis, Paradoxical reaction
Case report
A 31-year-old female presented to the Hospital for Tropical Diseases (Ho Chi Minh City, Vietnam) with a 3-week history of fever and headache. There was no relevant past medical history. On examination she was confused (Glasgow coma score 13/15) with no focal neurological signs. Vital signs were unremarkable. A chest X-ray did not show appearances consistent with pulmonary or miliary tuberculosis. HIV testing was negative. Cerebrospinal fluid (CSF) parameters were as follows: white blood cells 676 cells/mm3 (83 % neutrophils), protein 1.64 g/L, glucose 0.47 mmol/L (paired serum glucose 5.8 mmol/L), and lactate 8.72 mmol/L. CSF Ziehl-Neelsen smear microscopy revealed acid-fast bacilli, and CSF GeneXpert MTB/RIF was positive for Mycobacterium tuberculosis with no mutations of rifampicin resistance. Tuberculous meningitis (TBM) was diagnosed, and first line anti-tuberculosis chemotherapy (rifampicin, isoniazid, pyrazinamide and ethambutol) was commenced. An 8-week tapering course of dexamethasone or placebo was administered (this was a double-blinded allocation in a host leukotriene A4 hydrolase genotype stratified clinical trial [1]). Baseline contrast-enhanced brain magnetic resonance imaging (MRI) was unremarkable (images A & B). Fully sensitive M. tuberculosis was cultured from CSF after 8 days. After four weeks of in-patient monitoring the patient was discharged home (Fig. 1).
Eight weeks later the patient returned to the same hospital, with markedly reduced visual acuity and clinical signs consistent with left 3rd and 6th cranial nerve palsies. Colour vision was unaffected. Repeat contrast-enhanced brain MRI revealed extensive tuberculous exudate filling the basal cisterns of the brain consistent with a severe paradoxical reaction of TBM (images C & D). High dose intravenous dexamethasone (initially 0.4 mg/kg/day, with tapering reduction over 8 weeks) was administered. The patient’s visual acuity gradually returned to near-normal over 3–4 weeks.
In TBM paradoxical inflammatory reactions are common yet difficult to predict. When severe, they may result in substantial neurological morbidity and death. Pathogenesis is uncertain however, they are often considered an excessive host immune response to dead or dying mycobacteria. [2,3] The wide spectrum of paradoxical reactions in TBM includes tuberculomas and arachnoiditis however, obstructive inflammatory basal exudate is highly specific [4]. Prompt host directed therapies such as corticosteroids may reduce chances of permanent neurological damage.
Funding
JD and GET are supported by the Wellcome Trust, UK. The funder had no role in the writing or submission of this manuscript.
Consent
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.
Author contributions
JD drafted the manuscript. JD, NTT, GET and NHP all contributed to the care of the patient. All authors reviewed and approved the submission.
Declaration of Competing Interest
The authors report no declarations of interest.
References
- 1.Donovan J., Phu N.H., Thao L.T.P. Adjunctive dexamethasone for the treatment of HIV-uninfected adults with tuberculous meningitis stratified by Leukotriene A4 hydrolase genotype (LAST ACT): study protocol for a randomised double blind placebo controlled non-inferiority trial. Wellcome Open Res. 2018;3:32. doi: 10.12688/wellcomeopenres.14007.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Thuong N.T.T., Thwaites G.E. Treatment-associated inflammatory deterioration in tuberculous meningitis: unpicking the paradox. J Infect Dis. 2017;215:665–667. doi: 10.1093/infdis/jiw565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Bell L.C.K., Breen R., Miller R.F., Noursadeghi M., Lipman M. Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis. Int J Infect Dis. 2015;32:39–45. doi: 10.1016/j.ijid.2014.12.030. [DOI] [PubMed] [Google Scholar]
- 4.Garg R.K., Malhotra H.S., Kumar N. Paradoxical reaction in HIV negative tuberculous meningitis. J Neurol Sci. 2014;340:26–36. doi: 10.1016/j.jns.2014.03.025. [DOI] [PubMed] [Google Scholar]